Tackling CMV in Transplant Recipients: Past, Present, and Future
Cytomegalovirus (CMV), a beta-herpesvirus capable of maintaining lifelong latency, presents a substantial risk to transplant recipients, resulting in significant morbidity and mortality among both hematopoietic stem cell and solid organ transplantation ...
Tal Schlaeffer-Yosef, Lior Nesher
doaj +1 more source
Exploring neural models for human cytomegalovirus infection studies [PDF]
This thesis explores the use of clinical CMV isolates in the validation of antiviral effects against CMV infection of human CNS models in the context of cCMV disease. Next, it elucidates the use of advanced human neuronal models in CMV research.
Mulder, L.A.
core
DISEASES CAUSED BY INFECTIONS CAUSED BY VARIOUS VIRUSES AND THE IMPORTANCE OF THEIR RISK FACTORS IN MODERN MEDICINE [PDF]
As is known, viral infections are important causes of damage to almost all organs of the human body and, as a result, the development of various diseases.
Abdullaev, U. M. +2 more
core +1 more source
Maribavir for cytomegalovirus retinitis: A case series and review of the literature. [PDF]
Shughoury A +6 more
europepmc +1 more source
Human cytomegalovirus (CMV) infection is the most prevalent infection affecting organ transplant recipients, and it is a cause of morbidity and mortality in patients undergoing kidney transplantation.
Ana Piedade +8 more
doaj
Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries. [PDF]
Prats JAGG +8 more
europepmc +1 more source
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation [PDF]
Brunello, Lucia +5 more
core +1 more source
Optimizing maribavir management: The role of health system specialty pharmacies in access, monitoring, and waste reduction. [PDF]
Donald DR +6 more
europepmc +1 more source
New evidence in the management of CMV infection: impact on prophylaxis and treatment. [PDF]
Fortún J.
europepmc +1 more source

